- NASDAQ: BBIG remains on the back foot despite risk appetite stormed markets.
- Meme stocks rebound on Wednesday, but Vinco Ventures extends its losing streak.
- Clearing up some earlier confusion, the official date for Cryptyde dividend shares has yet to be announced.
Update September 24: The bearish pressure around NASDAQ: BBIG remained unabated, as the stock price extended its losing streak into the third consecutive day. The shares of Vinco Ventures lost 5% but managed to defend the $6 mark at the close. The upbeat risk tone on Wall Street indices failed once again to offer any respite to BBIG stock. Investors remain on tenterhooks ahead of the October 15 vote on the proposal for company spinoff Cryptyde to operate as its own publicly traded entity.
NASDAQ:BBIG just cannot seem to correct its recent downward trend, even when the markets are bouncing back from a recent sell off. On Wednesday, shares of BBIG fell by a further 2.95% and closed the trading session at $6.57. Unlike the volatility seen on Monday and Tuesday, Wednesday’s session brought a nice recovery as all three major U.S. indices climbed higher by about 1.0%. The NASDAQ led the way as the Federal Reserve is holding interest rates steady which of course benefits growth sectors more than cyclicals. The Fed did warn that tapering in bond purchasing could come sooner rather than later, as the U.S. economy continues to improve following the COVID-19 pandemic.
Stay up to speed with hot stocks' news!
Vinco Ventures’ performance on Wednesday was not indicative of the broader meme sector though. AMC (NYSE:AMC) and GameStop (NYSE:GME) stopped their recent skids and gained 3.25% and 0.10% respectively. Meanwhile other prominent meme names like ContextLogic (NASDAQ:WISH) gained 1.03% after seeing its price drop for the past few sessions as well. The sentiment surrounding Vinco Ventures is starting to sour on social media, as the stock’s losing streak extended to four days leading back to last week, and has now dropped nearly 16% in that time.
BBIG stock forecast
There was some confusion following an investor presentation from Vinco Ventures about the ex-dividend date for its soon to be public subsidiary Cryptyde. The date that was previously believed to be the ex-dividend date to receive shares of the spinoff was September 15th, but further investigation shows that the date has not yet been announced. October 15th is the confirmed date of record for the Cryptyde spinoff, so investors who want the dividends should buy shares of BBIG before then.
Previous updates
Update: NASDAQ:BBIG shed 5.02% on Thursday, ending the day at $6.24 per share. Wall Street posted substantial gains amid relief news coming from China, as Evergrande, the property giant, will likely avoid default. The Dow Jones Industrial Average added 507 points while the S&P 500 closed 56 points higher. The Nasdaq Composite was up 155 points or 1.04%.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD extends gains above 1.0700, focus on key US data
EUR/USD meets fresh demand and rises toward 1.0750 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold closes below key $2,318 support, US GDP holds the key
Gold price is breathing a sigh of relief early Thursday after testing offers near $2,315 once again. Broad risk-aversion seems to be helping Gold find a floor, as traders refrain from placing any fresh directional bets on the bright metal ahead of the preliminary reading of the US first-quarter GDP due later on Thursday.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price.
Meta takes a guidance slide amidst the battle between yields and earnings
Meta's disappointing outlook cast doubt on whether the market's enthusiasm for artificial intelligence. Investors now brace for significant macroeconomic challenges ahead, particularly with the release of first-quarter GDP data.